This randomized , double-blind , parallel group study in 694 chemotherapy nave patients undergoing cisplatin-based chemotherapy for solid tumors compared three different oral doses of NETU ( 100 , 200 , and 300 mg ) + PALO 0.50 mg with oral PALO 0.50 mg , all given on day 1 .